BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16271810)

  • 1. Duration of anticoagulation: decision making based on absolute risk.
    Keeling D
    Blood Rev; 2006 May; 20(3):173-8. PubMed ID: 16271810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry.
    Spirk D; Husmann M; Willenberg T; Banyai M; Frank U; Baldi T; Amann-Vesti B; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Feb; 105(2):239-44. PubMed ID: 20886197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
    East AT; Wakefield TW
    Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Clin Geriatr Med; 2006 Feb; 22(1):113-34, ix. PubMed ID: 16377470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended treatment for venous thromboembolism: how long is long enough?
    Cosmi B; Palareti G
    Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation after a first episode of venous thromboembolism: how long? How strong?
    Watzke HH
    Thromb Haemost; 1999 Sep; 82 Suppl 1():124-6. PubMed ID: 10695502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of deep vein thrombosis.
    Couturaud F; Kearon C
    Semin Vasc Med; 2001; 1(1):43-54. PubMed ID: 15199513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].
    Ferrari E; Schiano N; Benhamou M; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1301-6. PubMed ID: 11794973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.
    Schulman S
    Wien Med Wochenschr; 1999; 149(2-4):66-9. PubMed ID: 10378327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulants in the treatment of deep vein thrombosis.
    Merli G
    Am J Med; 2005 Aug; 118 Suppl 8A():13S-20S. PubMed ID: 16125510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic venous thrombosis. Long-term anticoagulant therapy? No.
    Kyrle PA
    Hamostaseologie; 2006 Jan; 26(1):52-4. PubMed ID: 16444323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S--a decision analysis.
    van den Belt AG; Hutten BA; Prins MH; Bossuy PM
    Thromb Haemost; 2000 Nov; 84(5):758-63. PubMed ID: 11127851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 1994 Mar; 71(3):286-91. PubMed ID: 8029791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
    Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
    Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.